contents area
Public Health Weekly Report
detail content area
A systematic review for the effect of emerging genome editing technology on laboratory biosafety
- Date2017-08-31 19:32
- Update2017-08-31 19:38
- DivisionDivision of Strategic Planning for Emerging Infectious Diseases
- Tel043-719-7271
A systematic review for the effect of emerging genome editing technology on laboratory biosafety
Yu minsu, Shin Haeng-Seop, Kang Yeon-Ho
Division of Biosafety Evaluation and Control, KNIH, KCDC
Lim Jae-Hwan
Department of biological science, Andong National University, South Korea
Background: Genome editing technology is a powerful tool for rewriting DNA sequences in all organisms. This technology is generally used in gene functional research, development of high value-added plant or animal models, and treatment of rare refractory diseases. It is the principle of modifying the characteristics of genes by cutting or repairing specific region in a gene.
Current status: Genome editing technology are divided into four generations depending on the types of nucleic acid digestion enzyme and gene targeting methods. Despite the advances in technology, there are still problems to solve such as off-target effect. Although genome editing technology is not inherently dangerous, it can increase exposure times and exposure concentrations due to inexpensive and easy testing methods. This may cause adverse effects and/or increase the number of risk factors such as off-target effect and alteration of expression profiles.
Future perspectives: A novel approach strategy for the safety of new recombinant technologies should be developed to ensure systematic laboratory biosafety with technical measures. Since the approach strategies applicable to each case vary, it is also necessary to study the standardization and improvement of the existing risk assessment systems such as the introduction of risk assessment factors on unintentional exposure and potential risks.
Yu minsu, Shin Haeng-Seop, Kang Yeon-Ho
Division of Biosafety Evaluation and Control, KNIH, KCDC
Lim Jae-Hwan
Department of biological science, Andong National University, South Korea
Background: Genome editing technology is a powerful tool for rewriting DNA sequences in all organisms. This technology is generally used in gene functional research, development of high value-added plant or animal models, and treatment of rare refractory diseases. It is the principle of modifying the characteristics of genes by cutting or repairing specific region in a gene.
Current status: Genome editing technology are divided into four generations depending on the types of nucleic acid digestion enzyme and gene targeting methods. Despite the advances in technology, there are still problems to solve such as off-target effect. Although genome editing technology is not inherently dangerous, it can increase exposure times and exposure concentrations due to inexpensive and easy testing methods. This may cause adverse effects and/or increase the number of risk factors such as off-target effect and alteration of expression profiles.
Future perspectives: A novel approach strategy for the safety of new recombinant technologies should be developed to ensure systematic laboratory biosafety with technical measures. Since the approach strategies applicable to each case vary, it is also necessary to study the standardization and improvement of the existing risk assessment systems such as the introduction of risk assessment factors on unintentional exposure and potential risks.
This public work may be used under the terms of the public interest source + commercial use prohibition + nonrepudiation conditions